secwatch.observer — SEC 8-K summary
======================================

Issuer:     PSYCHEMEDICS CORP (PMDI)
CIK:        0000806517
Form:       8-K
Filed at:   2024-08-13T23:59:59+00:00
Accession:  0001171843-24-004747
Event type: earnings
Sentiment:  negative
Materiality: 0.55
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Psychemedics Q2 revenue down 15% to $4.7M; net loss widens to $0.14/sh
----------------------------------------------------------------------

- Q2 2024 revenue $4.7M vs $5.5M YoY (-15%); net loss $0.8M ($0.14/sh) vs $0.7M ($0.13/sh).
- H1 2024 revenue $10.1M vs $11.4M YoY (-12%); net loss $1.5M ($0.26/sh) vs $1.1M ($0.19/sh).
- CEO cites continued lower client hiring as primary driver of revenue decline.
- Company adjusting operating costs while seeking new markets and applications.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/806517/000117184324004747/0001171843-24-004747-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/806517/000117184324004747/f8k_081324.htm
  HTML page:      https://secwatch.observer/filing/0001171843-24-004747

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer